publication venue for
- Non-Sexual Pelvic Inflammatory Disease in a Virginal Patient Resulting in Catatonic Conversion Reaction. 32:306-308. 2016
- Re: Incidence of de Novo Pelvic Pain After Radiofrequency or Thermal Balloon Global Endometrial Ablation Therapy. 30:254-254. 2014
- Essure Sterilization in Patients with History of Pelvic Inflammatory Disease and Hydrosalpinges: An Analysis on Feasibility and Clinical Outcomes. 28:343-346. 2012
- Hospital Cost Savings Associated with the Use of an Adhesion Barrier During Cesarean Delivery. 28:207-211. 2012
- Office Versus Hospital Based Essure Procedure: Pareto Principle in Action. 28:16-19. 2012
- Patient Sequelae and Accrued Health Care Costs from Intra-Abdominal/Pelvic Adhesions. 28:121-126. 2012
- Three-Year Prospective Menstrual and Dysmenorrhea Outcomes after ThermachoiceIII in-Office Therapy. 28:350-354. 2012
- Essure Sterilization with Sonographic Confirmation Test: Protocol Description and Clinical Outcomes Using Ultrasound as an Essure Confirmation Test. 27:57-62. 2011
- Incidence of de Novo Pelvic Pain After Radiofrequency or Thermal Balloon Global Endometrial Ablation Therapy. 27:203-207. 2011
- Thermal Balloon Endometrial Ablation in Patients with Prior Low Transverse Cesarean Section: Safety Analysis and Protocol Description. 27:63-66. 2011
- Menstrual and Dysmenorrhea Outcomes After Thermachoice III: A 2-Year Prospective Study. 26:233-236. 2010
- The Paucity of Information on Adhesions After Cesarean Delivery. 26:255-260. 2010